SITAGIX-100MG TAB

Distributor inventory | Tablet

Type 2 diabetes mellitus to improve glycaemic control along with diet and exercise; used alone or in combination with other antidiabetic medicines (e.g., metformin, sulfonylurea, insulin) as prescribed.

Sitagliptin is a DPP-4 inhibitor. It increases levels of incretin hormones (GLP-1 and GIP), which enhance glucose-dependent insulin release and reduce glucagon secretion, helping lower blood sugar with a low risk of hypoglycaemia when used alone.

Oral tablet. Take as directed by a doctor, usually once daily, with or without food, at the same time each day. Dose adjustment may be needed in kidney disease; do not stop or change dose without medical advice.

Headache, nasopharyngitis, upper respiratory tract infection, nausea, diarrhoea, stomach discomfort

Not for type 1 diabetes or diabetic ketoacidosis. Use with caution in kidney impairment (dose adjustment required); monitor renal function. Rare risk of pancreatitis—seek care for severe persistent abdominal pain. Hypoglycaemia risk increases when combined with sulfonylureas/insulin. Severe joint pain and serious allergic reactions (rash, angioedema, anaphylaxis) have been reported; stop and seek medical help if symptoms occur.

Insulin, sulfonylureas (e.g., glimepiride) (increased hypoglycaemia risk), digoxin (may increase digoxin levels), strong inducers affecting glycaemic control (e.g., corticosteroids, thiazide diuretics)

Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Januvia 100 mg Tablet, Istavel 100 mg Tablet, Zita 100 mg Tablet, Sitasafe 100 mg Tablet, Sitagliptin 100 mg Tablet (generic)